BACKGROUND: The aim of this study was to retrospectively analyze the pathological outcomes of patients meeting the Prostate Cancer Research International Active Surveillance (PRIAS) criteria who had undergone radical prostatectomy (RP). METHODS: Out of 2014 patients recruited for minimally invasive RP between 2008 and 2014 in 7 centers, 226 (11.2%) met the modified PRIAS criteria (clinical stage T1c/T2, PSA<10 ng/mL, 1-2 positive biopsy cores and Gleason Score<6). RESULTS: At pathological evaluation, Gleason Score upgrade was reported in 47.3% of patients; 74 (32.7%), 10 (4.4%), 9 (3.9%) patients showed RP Gleason sum 7, 8 and 9, respectively. Upstaging was reported in 135 patients (59.7%). Twelve (5.3%) and 4 (1.7%) patients had T3a and T3b pathological stage respectively. CONCLUSIONS: Notwithstanding the PRIAS criteria can identify some PCa patients as low-risk, at pathological evaluation some of them harbored intermediate- or high-risk disease. According to our data, patients eligible for AS should be carefully counseled about possible disease understaging.
BACKGROUND: The aim of this study was to retrospectively analyze the pathological outcomes of patients meeting the Prostate Cancer Research International Active Surveillance (PRIAS) criteria who had undergone radical prostatectomy (RP). METHODS: Out of 2014 patients recruited for minimally invasive RP between 2008 and 2014 in 7 centers, 226 (11.2%) met the modified PRIAS criteria (clinical stage T1c/T2, PSA<10 ng/mL, 1-2 positive biopsy cores and Gleason Score<6). RESULTS: At pathological evaluation, Gleason Score upgrade was reported in 47.3% of patients; 74 (32.7%), 10 (4.4%), 9 (3.9%) patients showed RP Gleason sum 7, 8 and 9, respectively. Upstaging was reported in 135 patients (59.7%). Twelve (5.3%) and 4 (1.7%) patients had T3a and T3b pathological stage respectively. CONCLUSIONS: Notwithstanding the PRIAS criteria can identify some PCa patients as low-risk, at pathological evaluation some of them harbored intermediate- or high-risk disease. According to our data, patients eligible for AS should be carefully counseled about possible disease understaging.
Authors: Angelo Porreca; Federico Mineo Bianchi; Antonio Salvaggio; Daniele D'Agostino; Alessandro Del Rosso; Daniele Romagnoli; Paolo Corsi; Michele Colicchia; Umberto Barbaresi; Lorenzo Bianchi; Marco Giampaoli; Riccardo Schiavina; Katie Palmer; Francesco Del Giudice; Martina Maggi; Matteo Ferro; Alessandro Sciarra; Ettore De Berardinis; Gian Maria Busetto Journal: World J Urol Date: 2020-07-03 Impact factor: 4.226
Authors: Angelo Porreca; Michele Colicchia; Daniele D'Agostino; Michele Amenta; Alfio Corsaro; Stefano Zaramella; Luisa Zegna; Fabrizio Gallo; Maurizio Schenone; Giorgio Bozzini; Alberto Calori; Antonio L Pastore; Yazan Al Salhi; Carmine Sciorio; Lorenzo Spirito; Virginia Varca; Carlo Marenghi; Francesco Greco; Vincenzo M Altieri; Paolo Verze; Ciro Barba; Alessandro Antonelli; Maria A Cerruto; Roberto Falabella; Silvana Di Bello; Costantino Leonardo; Antonio Tufano; Alessandro Volpe; Paolo Umari; Paolo Parma; Mattia Nidini; Giovannalberto Pini; Marco Borghesi; Carlo Terrone; Giovanni E Cacciamani; Maria C Sighinolfi; Gian Maria Busetto; Alexandra M Wennberg; Marinella Finocchiaro; Mario Falsaperla; Marco Oderda; Carlo Ceruti; Bernardo Rocco; Riccardo Schiavina; Lorenzo Bianchi; Andrea Mari; Fabrizio Di Maida; Orietta Dalpiaz; Antonio Celia; Marco Pirozzi; Pierluigi Bove; Valerio Iacovelli; Angelo Cafarelli; Luca Cindolo; Giovanni Ferrari; Lorenzo Gatti; Giacomo Pirola; Filippo Annino; Luigi Pucci; Daniele Romagnoli; Walter Artibani; Andrea Minervini Journal: Urol Int Date: 2020-05-20 Impact factor: 2.089
Authors: Gian Maria Busetto; Francesco Del Giudice; Andrea Mari; Isabella Sperduti; Nicola Longo; Alessandro Antonelli; Maria Angela Cerruto; Elisabetta Costantini; Marco Carini; Andrea Minervini; Bernardo Rocco; Walter Artibani; Angelo Porreca; Francesco Porpiglia; Rocco Damiano; Marco De Sio; Davide Arcaniolo; Sebastiano Cimino; Giorgio Ivan Russo; Giuseppe Lucarelli; Pasquale Di Tonno; Paolo Gontero; Francesco Soria; Carlo Trombetta; Giovanni Liguori; Roberto Mario Scarpa; Rocco Papalia; Carlo Terrone; Marco Borghesi; Paolo Verze; Massimo Madonia; Antonello De Lisa; Pierluigi Bove; Giorgio Guazzoni; Giovanni Lughezzani; Marco Racioppi; Luca Di Gianfrancesco; Eugenio Brunocilla; Riccardo Schiavina; Claudio Simeone; Alessandro Veccia; Francesco Montorsi; Alberto Briganti; Fabrizio Dal Moro; Carlo Pavone; Vincenzo Serretta; Savino Mauro Di Stasi; Andrea Benedetto Galosi; Luigi Schips; Michele Marchioni; Emanuele Montanari; Giuseppe Carrieri; Luigi Cormio; Francesco Greco; Gennaro Musi; Martina Maggi; Simon L Conti; Andrea Tubaro; Ettore De Berardinis; Alessandro Sciarra; Michele Gallucci; Vincenzo Mirone; Ottavio de Cobelli; Matteo Ferro Journal: Front Surg Date: 2020-11-24
Authors: Angelo Porreca; Francesco Del Giudice; Marco Giampaoli; Daniele D'Agostino; Daniele Romagnoli; Paolo Corsi; Alessandro Del Rosso; Martina Maggi; Benjamin I Chung; Matteo Ferro; Ottavio de Cobelli; Giuseppe Lucarelli; Riccardo Schiavina; Ettore De Berardinis; Alessandro Sciarra; Gian Maria Busetto Journal: Medicine (Baltimore) Date: 2020-09-11 Impact factor: 1.817